DECMAX INJECTION
Description
Decmax is the first high dose dexamethasone formulated specially for the convenience of cancer patients. The availability of dexamethasone 4 mg tablets and 8 mg inj. and tablets have made dosing very convenient in several areas of cancer treatment. Premedication before taxane administration to avoid hypersensitivity reactions (HSR), prophylaxis of chemotherapy induced nausea and vomiting (CINV), treatment of peritumoral edema in patients with brain tumours and in B-Cell malignancies like Multiple Myeloma, administration of 4-20 mg of dexamethasone is common.
Indications:
- Control of severe or incapacitating allergic conditions
- Dermatologic Diseases
- Endocrine Disorders
- Gastrointestinal Diseases
- Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults, pure red cell aplasia, and selected cases of secondary thrombocytopenia
- Diagnostic testing of adrenocortical hyperfunction, trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy
- For the palliative management of leukemias and lymphomas
- Acute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumour, craniotomy, or head injury
- Sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.
- To induce a diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus.
- Respiratory Diseases
- Rheumatic Disorders
| Generic Name | Strength | Standard | Type | Packing | Pack Size |
| Dexamethasone | 4 mg | IP | Tablet | Strip | 1x10s |
| Dexamethasone | 8 mg | IP | Tablet | Strip | 1x10s |
| Dexamethasone | 8 mg | IP | Injection | vials | 2ml Vial |